TECH · NASDAQ
BIO-TECHNE (TECH) Stock Price & Fundamentals
BIO-TECHNE (TECH) closed at $854.73 on Oct 9, 2026, down 0.13% from the previous close of $855.81.
Share price, past year
1Y +11.42%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $854.73 |
| Sep 30, 2026 | $822.73 |
| Aug 31, 2026 | $817.82 |
| Jul 31, 2026 | $796.21 |
| Jun 30, 2026 | $808.22 |
| May 29, 2026 | $780.61 |
| Apr 30, 2026 | $825.74 |
| Mar 31, 2026 | $791.62 |
| Feb 27, 2026 | $814.56 |
| Jan 30, 2026 | $781.72 |
| Dec 31, 2025 | $762.64 |
| Nov 28, 2025 | $794.26 |
| Oct 31, 2025 | $824.64 |
Key statistics
- Market cap
- $133.42B
- P/E (TTM)
- 909.3
- EPS (TTM)
- $0.94
- Revenue (TTM)
- $1.22B
- Net income (TTM)
- $109.56M
- Shares outstanding
- 156.1M
- Dividend yield
- 0.04%
- 52-week range
- $748.61 – $855.81
BIO-TECHNE's market cap is $133.42B, based on a share price of $854.73 and 156.1M shares outstanding as of Jun 30, 2026.
Financials
BIO-TECHNE reported revenue of $1.22B for fiscal 2026, down 0.38% from fiscal 2025.
BIO-TECHNE earned net income of $73.40M in fiscal 2025, a net margin of 6.0%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jun 30, 2026 | $1.22B | −0.4% | — | — | $1.16 | $263.22M |
| FY2025ended Jun 30, 2025 | $1.22B | +5.2% | $73.40M | 6.0% | $0.46 | $256.55M |
| FY2024ended Jun 30, 2024 | $1.16B | +2.0% | $168.11M | 14.5% | $1.05 | $236.10M |
| FY2023ended Jun 30, 2023 | $1.14B | +2.8% | $285.26M | 25.1% | $1.76 | $216.15M |
| FY2022ended Jun 30, 2022 | $1.11B | +18.8% | $272.05M | 24.6% | $1.66 | $280.36M |
| FY2021ended Jun 30, 2021 | $931.03M | +26.0% | $140.41M | 15.1% | $0.87 | $307.86M |
| FY2020ended Jun 30, 2020 | $738.69M | +3.5% | $229.30M | 31.0% | $1.46 | $153.47M |
| FY2019ended Jun 30, 2019 | $714.01M | +11.0% | $96.07M | 13.5% | $0.6175 | $156.21M |
| FY2018ended Jun 30, 2018 | $642.99M | +14.2% | $126.15M | 19.6% | $0.8275 | $149.43M |
| FY2017ended Jun 30, 2017 | $563.00M | — | $76.09M | 13.5% | $0.5075 | $128.54M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2026ended Jun 30, 2026 | $321.19M | — | — |
| Q3 FY2026ended Mar 31, 2026 | $311.42M | $51.05M | $0.32 |
| Q2 FY2026ended Dec 31, 2025 | $295.88M | $38.01M | $0.24 |
| Q1 FY2026ended Sep 30, 2025 | $286.56M | $38.19M | $0.24 |
| Q4 FY2025ended Jun 30, 2025 | $316.97M | −$17.68M | — |
| Q3 FY2025ended Mar 31, 2025 | $316.18M | $22.59M | $0.14 |
| Q2 FY2025ended Dec 31, 2024 | $297.03M | $34.89M | $0.22 |
| Q1 FY2025ended Sep 30, 2024 | $289.46M | $33.60M | $0.21 |
Company profile
- Name
- BIO-TECHNE Corp
- Ticker
- TECH
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 614 Mckinley Place Ne, Minneapolis, MN
- Incorporated in
- MN
- Fiscal year ends
- June
- SEC CIK
- 0000842023
Recent SEC filings
- Sep 23, 2026
- Sep 14, 2026
- Aug 24, 2026
- Aug 12, 2026
- Jun 26, 2026
- Jun 25, 2026
- May 6, 2026
- May 6, 2026
Frequently asked questions
What is BIO-TECHNE's stock price?
BIO-TECHNE (TECH) closed at $854.73 on Oct 9, 2026, down 0.13% from the previous close of $855.81.
What is BIO-TECHNE's market cap?
BIO-TECHNE's market cap is $133.42B, based on a share price of $854.73 and 156.1M shares outstanding as of Jun 30, 2026.
How much revenue does BIO-TECHNE make?
BIO-TECHNE reported revenue of $1.22B for fiscal 2026, down 0.38% from fiscal 2025.
What is TECH's P/E ratio?
BIO-TECHNE's price-to-earnings ratio is 909.3, based on trailing twelve-month diluted EPS of $0.94.
Does BIO-TECHNE pay a dividend?
Yes. BIO-TECHNE declared $0.32 per share in dividends over the last four quarters, a yield of 0.04%.
Sources and methodology
Fundamentals come from BIO-TECHNE Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures